Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: A retrospective clinico-pathological study of the Tohoku gynecologic cancer unit

Tohoku Journal of Experimental Medicine

Volumn 223, Issue 2, 2011, Pages 91-96

  Kojimahara, Takanobu ^a   Nakahara, Kenji ^a   Shoji, Tadahiro ^b   Sugiyama, Toru ^b   Takano, Tadao ^c   Yaegashi, Nobuo ^c   Yokoyama, Yoshihito ^d   Mizunuma, Hideki ^d   Tase, Ryo ^e   Satou, Hirokazu ^f   Tanaka, Toshinobu ^f   Motoyama, Teiichi ^a   Kurachi, Hirohisa ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

^e Miyagi Cancer Center   (Japan)

^f AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinico pathological analysis; Intraperitoneal chemotherapy; Prognostic factors; Pseudomyxoma peritonei; Retrospective multicenter study

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; ILEUS; JAPANESE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OVARY TUMOR; OVERALL SURVIVAL; PATHOLOGY; PELVIC INFLAMMATORY DISEASE; PERITONEUM PSEUDOMYXOMA; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GYNECOLOGY; HUMANS; JAPAN; MIDDLE AGED; ONCOLOGY SERVICE, HOSPITAL; PERITONEAL NEOPLASMS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79251519324     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.223.91     Document Type: Review

References (16)

1. Baratti, D.B., Kusamura, S., Nonaka, D., Langer, M., Andreola, S., Favaro, M., Gavazzi, C., Laterza, B. & Deraco, M. (2008) Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intra-abdominal chemotherapy (HIPEC). Ann. Surg. Oncol., 15, 526-534.
2. Esquivel, J. & Sugarbaker, P.H. (2000) Clinical presentation of the pseudomyxoma peritonei syndrome. Br. J. Surg., 87, 1414-1418.
3. Gough, D.B., Donohue, J.H., Schutt, A.J., Gonchoroff, N., Goellner, J.R., Wilson, T.O., Naessens, J.M., O'Brien, P.C. & van Heerden, J.A. (1994) Pseudomyxoma peritonei. Longterm patient survival with an aggressive regional approach. Ann. Surg., 219, 112-119.
4. Kataoka, A., Yakushiji, M., Sugiyama, T., Nishida, T., Nagasue, N. & Kawano, K. (1989) Clinicopathological study on pseudomyxoma peritonei. Nippon Sanka Fujinka Gakkai Zasshi, 41, 1769-1775. (in Japanese).
5. Lee, J.K., Song, S.H., Kim, I., Lee, K.H., Kim, B.G., Kim, J.W., Kim, Y.T., Park, S.Y., Cha, M.S. & Kang, S.B. (2008) Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005). Int. J. Gynecol. Cancer, 18, 916-920.
6. Mann, W.J. Jr., Wagner, J., Chumas, J. & Chalas, E. (1990) The management of pseudomyxoma peritonei. Cancer, 66, 1636-1640.
7. Miner, T.J., Shia, J., Jaques, D.P., Klimstra, D.S., Brennan, M.F. & Coit, D.G. (2005) Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann. Surg., 241, 300-308.
8. Ronnett, B.M., Kajdacsy-Balla, A., Gilks, C.B., Merino, M.J., Silva, E., Werness, B.A. & Young, R.H. (2004) Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum. Pathol., 35, 949-960.
9. Ronnett, B.M., Kurman, R.J., Zahn, C.M., Shmookler, B.M., Jablonski, K.A., Kass, M.E. & Sugarbaker, P.H. (1995) Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum. Pathol., 26, 509-524.
10. Ronnett, B.M., Shmookler, B.M., Diener-West, M., Sugarbaker, P.H. & Kurman, R.J. (1997) Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma paeitonei in women. Int. J. Gynecol. Pathol., 16, 1-9.
11. Smeenk, R.M., van Velthuysen, M.L.F., Verwaal, V.J. & Zoetmulder, F.A. (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur. J. Surg. Oncol., 34, 196-201.
12. Sugarbaker, P.H. (1995) Peritonectomy procedures. Ann. Surg., 221, 29-42.
13. Sugarbaker, P.H. (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol., 7, 69-76.
14. Szych, C., Staebler, A., Connolly, D.C., Wu, R., Cho, K.R. & Ronnett, B.M. (1999) Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in woman. Am. J. Pathol., 154, 1849-1855.
15. Tavassoli, F.A. & Devilee, P. (2003) Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Organization Classification of Tumours. IARC Press, Lyon.
16. Yan, T.D., Black, D., Savady, R. & Sugarbaker, P.H. (2007) A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann. Surg. Oncol. 14, 484-492.